http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104755482-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eb6dbca25e5f9459a6c5f592728c787
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
filingDate 2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_057ab9f2db6e60eb7d52677a72abc840
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c81d4854a91dda8b82e2755f71f3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09c7cb01e9e27886e850a68b6968041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f50071bc4c91facf0fe38364954ea3
publicationDate 2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104755482-A
titleOfInvention Functionalized 9-bromo-camptothecin derivatives
abstract The present invention relates to novel functionalized 9-bromo-camptothecin derivatives (I), which have cytotoxic activity and are useful in the treatment of diseases such as cancer, cell proliferative disorders and viral infections. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising them and methods of using the compounds or pharmaceutical compositions comprising them for treating diseases. The present invention also relates to the use of these functionalized 9-bromo-camptothecin derivatives for the preparation of conjugates.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106188094-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113286796-A
priorityDate 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9835940-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0149691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4943579-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID144617446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74762965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465398764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152870813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425131461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420129047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90153272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431416999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414160442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465810826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13952658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13984308

Total number of triples: 48.